Po­laris cash­es in its chips as Langer-backed Ar­sia is auc­tioned off to Ea­gle for up to $78M

Re­cent­ly frus­trat­ed in its at­tempt to win a reg­u­la­to­ry ap­proval at the FDA, Ea­gle Phar­ma­ceu­ti­cals $EGRX has swooped in to buy Po­laris-backed Ar­sia Ther­a­peu­tics for …

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER